We’ve helped companies succeed with urology trials including benign prostatic hyperplasia, overactive bladder and incontinence. Our customised solutions and results-focused approach to patient enrolment and retention help keep trials on schedule and ensure vital research funds are used effectively. Our global investigator network includes more than 1,000 urologists, nephrologists, internists and obstetricians/gynecologists. With global experience across multiple urology indications, we have conducted trials in recent years in the following:

Areas of expertise include

  • Benign prostatic hyperplasia (BPH)
  • Erectile dysfunction
  • Kidney/renal disease
  • Lower urinary tract symptoms (LUTS)
  • Nocturia
  • Osteoporosis
  • Overactive bladder
  • Premature ejaculation
  • Stress incontinence
  • Urge incontinence

More than

10.3K

patients randomised

Urological

255

studies performed